New Alliance Capital

New Alliance Capital is a venture capital and private equity firm founded in 2008 and headquartered in Shanghai, China. The firm specializes in early-stage, growth-stage, and pre-IPO investments across a diverse range of sectors, including high-end manufacturing, technology, advanced agriculture, consumer goods, information, media, energy, recycling, environmental protection, and modern services. New Alliance typically invests amounts ranging from approximately $4.71 million to $31.41 million. In addition to its investments in China, the firm also focuses on private equity opportunities in the United States, particularly in the technology, media, and telecommunications (TMT), cultural media, healthcare, and energy sectors.

Zonghe Wu

Partner

88 past transactions

Core Medical Technology

Series D in 2025
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

Pu Enjing

Series B in 2025
Pu Enjing engaged in the independent research and development of high-end polymer materials.

Huali Juneng

Seed Round in 2024
Huali Juneng is a pressure vessel and related equipment producer specializing in petroleum, chemical, oil, electricity, desalination, and medical.

Positive Sequence Biology

Series A in 2024
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

Stepin

Seed Round in 2024
Stepin is a cross-border jewelry brand that specializes in AI jewelry cross-border e-commerce.

Arnatar Therapeutics

Series A in 2024
Arnatar Therapeutics is a biopharmaceutical company that specializes in the development of novel nucleic acid medications.

Elite Technology

Angel Round in 2024
Elite Technology is a company that specializes in the development of chromatographic techniques, workstations, and high-performance liquid chromatography equipment for analysis, preparation, and industrial production.

Chelion

Venture Round in 2024
Chelion specializes in providing one-stop energy storage solutions. It is committed to providing the world with affordable and renewable green energy.

Rongmai Medical

Venture Round in 2024
Rongmai Medical is a producer of medical devices for peripheral vascular interventions.

LYNK Pharmaceuticals

Series C in 2023
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Xbotspace

Series A in 2023
Xbotspace is a generative AI middleware startup focused on the implementation and deployment of large language models. The company develops artificial intelligence middleware that facilitates decision-making by allowing employees to communicate requests in natural language and schedule agents to execute tasks. Xbotspace's technology aims to connect people and systems while mining and extracting valuable business data, ultimately helping organizations optimize their business processes. Through its innovative approach, Xbotspace seeks to enhance operational efficiency and streamline how enterprises manage their workflows.

ECCOGENE

Series B in 2023
Eccogene is a clinical stage biopharmaceutical company focused on developing therapeutic solutions for unmet medical needs, particularly in the areas of metabolic and immune-related diseases. The company specializes in disease biology, medicinal chemistry, and translational science, with the aim of creating innovative pharmaceuticals that target complex chronic conditions such as obesity and diabetes. Eccogene is dedicated to advancing its pipeline of metabolic drugs to enhance patient outcomes and address significant health challenges.

Lips Semiconductor

Series B in 2023
Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.

Dongguan nRuiT Energy Technology

Seed Round in 2023
Provider, manufacturer and developer of energy storage solutions designed for multiple scenarios. The company provides energy storage systems for family, business and portable situations, enabling clients with energy storage solutions.

Guanan Information

Venture Round in 2023
Guanan Information is a technology-driven enterprise that provides big data and pan-security services. It focuses on core directions such as data security, cyberspace security, 5G security, artificial intelligence security, industrial Internet security, and public security. Guanan Information also provides information security solutions for operators, government, finance, electric power, public security, military, medical and other industries.

ProBio

Series C in 2023
ProBio Inc. is a one-stop biopharmaceutical R&D and production platform. It provides end-to-end services for cell and gene therapy drugs, vaccine and biopharmaceutical discovery, antibody protein drugs.

Yike Polymers

Series B in 2023
Eco Polymer specializes in designing and manufacturing plastic tubes and parts. They provide products for polyethylene, polypropylene, polyamine, elastomers, fluoropolymers, and other various polymers. They serve the medical instrument, auto, electronics, fiber optics, semiconductor, chemical engineering, environment, and analytics industries.

Yibo Semiconductor

Venture Round in 2023
Yibo Semiconductor is a advanced semiconductor packaging design, materials, processes and manufacturing company.

Core Medical Technology

Series C in 2022
Core Medical Technology is a technology enterprise mainly engaged in the research, production, development, and sales of implantable left ventricular assist devices, extracorporeal ventricular assist devices, percutaneous interventional ventricular assist devices, and equipment. The company was founded in 2016 and is based in Shenzhen, China.

NeuroXess

Series A in 2022
NeuroXess is a high-tech life science company focusing on flexible electrode BCI (Brain-computer interface) technologies to protect and explore the brain.

Indiemicro

Series B in 2022
Indie microelectronics combines R&D, testing, platform development, application development, technical support, and sales centers. Sales and technical support centers have been established in Shanghai, Shenzhen, and Taipei with a focus on supporting semiconductor products for Great China customers.

Ideal Energy Sunflower

Private Equity Round in 2022
Ideal Energy Sunflower specializes in the development of Plasma Enhanced Chemical Vapor Deposition (PECVD) equipment in China. Established in 2013 following a reorganization, the company focuses on high-end PECVD solutions for the photovoltaic and AMOLED display sectors. Ideal Energy Sunflower has made significant strides in breaking foreign monopolies within these industries and has successfully filled domestic gaps in high-end equipment supply. The company's advanced products are recognized for their cost efficiency and technological innovation, making it a preferred supplier in the Chinese market for high-end PECVD equipment.

Solinteg

Series A in 2022
Solinteg is a technology-focused company specializing in advanced energy storage solutions. It offers a range of products, including solar inverters, batteries, smart terminals, monitoring devices, and energy management services (EMS), designed to intelligently integrate solar energy into distributed grids.

Kactus Biosystems

Series B in 2022
KACTUS is a biotechnology firm that specializes in the research and development of targeted protein tools. The company provides biotechnology-based services aimed at advancing various applications in the field. Through its innovative approaches, KACTUS seeks to contribute to the development of effective solutions in the biotechnology sector.

Degron Therapeutics

Series A in 2022
Degron Therapeutics is a drug discovery company focused on developing a new class of therapeutics centered around targeted protein degradation. The company specializes in molecular glue degrader drugs, which are small molecules designed to selectively target and degrade specific proteins associated with various diseases. Degron Therapeutics aims to lead the field of small molecule molecular glue degrader medicines by leveraging its expertise to identify and validate challenging disease targets that traditional small molecule inhibitors cannot effectively address. The company is committed to addressing unmet medical needs across a broad range of therapeutic areas by developing innovative protein degradation drugs, utilizing its advanced molecular glue platform technology to enhance treatment efficacy.

Yuntu Semiconductor

Series A in 2022
Yuntu Semiconductor is a fabless semiconductor and integrated circuit developer specializing in automotive-grade chips. The company designs and develops semiconductors tailored for the automotive industry, utilizing its proprietary integrated circuit design and verification platform. This enables Yuntu Semiconductor to offer clients comprehensive solutions for automotive-grade chipsets, addressing the specific needs of modern automotive applications.

ATAPEX

Series A in 2022
ATAPEX specializes in the large-scale mass production of precision metal masks essential for the fabrication of OLED panels and other high-end display technologies. The company addresses the challenges faced by its clients, such as limited product options, inconsistent quality, and lengthy delivery times. Its product portfolio includes advanced solutions like Divide Open Masks and Fine Metal Masks for AMOLED displays, as well as Micro OLED Open Masks designed for silicon-based OLED applications. By integrating these products into a cohesive industry chain, ATAPEX aims to enhance the performance and reliability of display manufacturing processes, thereby supporting the needs of various display terminal sectors, including virtual and augmented reality technologies.

Angstrong

Series B in 2022
Angstrong Tech is a developer and manufacturer specializing in 3D sensing and smart hardware solutions. Headquartered in Shenzhen, with additional branches in Shanghai and the United States, the company focuses on creating advanced 3D sensing technology for diverse applications across various industries. These include mobile phones, personal computers, security surveillance, facial recognition, smart driving, medical technology, and smart homes. Angstrong's innovations enhance user experiences in areas such as augmented and virtual reality, robotic operations, and smart retail. The company's commitment to quality and innovation positions it as a leader in the smart hardware market.

Lips Semiconductor

Series A in 2022
Lipps is a research and development, production and sales company of power semiconductor components. It can independently design IGBT/SIC, MOSFET modules and IPM module products, and has established a cooperative relationship with Japanese power module packaging factories.

Harvest Integrated Research Organization

Series A in 2022
Harvest Integrated Research Organization (HiRO) is an innovative clinical research organization (CRO) with a global presence. It offers a comprehensive suite of services tailored for biotechnology and pharmaceutical companies, including pre-clinical strategic planning, clinical trial design, regulatory affairs, pharmacovigilance, statistics, data management, and end-to-end project management. HiRO is committed to facilitating the transition of pharmaceutical products from the laboratory to the market, collaborating closely with its clients to develop more effective and cost-efficient therapies for patients worldwide. As an emerging leader in the CRO sector, HiRO aims to enhance the drug development process through its integrated capabilities and dedication to quality.

NeuroXess

Angel Round in 2022
NeuroXess is a high-tech life science company focusing on flexible electrode BCI (Brain-computer interface) technologies to protect and explore the brain.

InnoStar Semiconductor

Series A in 2022
InnoStar Semiconductor is a developer and provider of advanced semiconductor storage technology, specializing in resistive random access memory (ReRam) chips. The company focuses on creating high-performance, low-power storage solutions tailored for applications in information security, Internet of Things (IoT), artificial intelligence (AI), and cloud computing. By commercializing its innovative ReRam technology, InnoStar aims to redefine storage capabilities and intelligent computing, enabling businesses to enhance security measures and meet the growing demands for efficient data storage and processing. Through its commitment to technological advancement, InnoStar Semiconductor is poised to set industry benchmarks in the semiconductor sector.

Yuntu Semiconductor

Series A in 2021
Yuntu Semiconductor is a fabless semiconductor and integrated circuit developer specializing in automotive-grade chips. The company designs and develops semiconductors tailored for the automotive industry, utilizing its proprietary integrated circuit design and verification platform. This enables Yuntu Semiconductor to offer clients comprehensive solutions for automotive-grade chipsets, addressing the specific needs of modern automotive applications.

LePure Biotech

Series B in 2021
LePure Biotech, established in 2011 and headquartered in Shanghai, China, operates within the biotechnology and pharmaceutical sectors. The company specializes in the development and manufacturing of disposable biopharmaceutical process equipment and consumables, primarily focusing on products that facilitate the storage, transportation, filling, and leak detection of samples related to biosimilars, vaccines, and other biopharmaceutical applications. Its core offering is a disposable storage bag designed to meet the specific needs of these processes. Recently, LePure Biotech completed a B+ round of financing, which aims to fund the development of innovative products, establish a research and development center in the United States, enhance supply chain integration, and expand its R&D operations both domestically and internationally.

Positive Sequence Biology

Series A in 2021
Positive Sequence Biology is a biotech company with new gene system-based editing, focused on biotech innovation & breakthrough therapies.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

MediTrust Health

Series C in 2021
MediTrust Health is a leading healthcare platform in China that offers a wide range of health insurance products and comprehensive medical services. The company connects pharmaceutical companies, insurers, hospitals, and patients, creating a cohesive ecosystem that benefits all stakeholders involved. By integrating high-quality medical resources with health insurance, MediTrust Health aims to deliver affordable, personalized healthcare solutions to families. In addition to its insurance offerings, the company focuses on improving the management of medical expenses and enhancing patient access to necessary services through innovative payment solutions. MediTrust Health's commitment to addressing the complexities of medical financing and providing diverse healthcare benefits positions it as a significant player in the healthcare industry.

Petkit

Series D in 2021
Shanghai PETKIT Network Technology Co., Ltd., founded in 2013, specializes in developing and manufacturing innovative pet care products. Based in Shanghai, China, the company offers a diverse range of smart devices designed to enhance the health and well-being of pets. Its product lineup includes smart feeders, antibacterial bowls, drinking fountains, and pet monitoring devices that track activity levels, calorie consumption, and overall health. Additionally, Petkit provides a mobile application that integrates with its smart devices, allowing pet owners to monitor their pets' behaviors and health metrics conveniently. By combining technology with pet care, Petkit aims to simplify pet management for owners while ensuring the welfare of their animals.

Infervision

Series D in 2021
Infervision is a Beijing-based artificial intelligence company specializing in medical imaging diagnosis through advanced deep learning technology and computer vision. The company develops innovative products aimed at enhancing the efficiency and accuracy of cancer diagnosis. Infervision's efforts led to the creation of the world's first artificial intelligence precise healthcare platform, along with intelligent X-ray and CT assisted diagnosis products, which are currently undergoing trials in several prestigious hospitals across China. The company is deeply committed to academic collaboration, partnering with leading institutions in Chinese Radiology to integrate medical science with technology. Infervision has established partnerships with nearly 20 top-tier hospitals, facilitating the seamless integration of medical data, technology, and application scenarios. This unique approach has enabled Infervision to build a comprehensive artificial intelligence computing platform and a precise healthcare intelligence system that supports medical professionals in delivering better diagnostic outcomes with increased efficiency and reduced costs.

Synlight Crystal

Series D in 2021
Synlight Crystal is a manufacturer specializing in silicon carbide substrates, crucial for third-generation semiconductors. The company produces stable N-type and semi-insulating silicon carbide wafers, catering to downstream customers in the semiconductor industry. Synlight Crystal has established a comprehensive production line that encompasses powder synthesis, crystal growth, cutting processes, and crystal inspection. This enables the company to deliver high-quality crystal substrates ranging from 4 to 6 inches in diameter. Through its advanced manufacturing capabilities, Synlight Crystal plays a significant role in meeting the growing demand for efficient and reliable semiconductor materials.

InnoStar Semiconductor

Seed Round in 2021
InnoStar Semiconductor is a developer and provider of advanced semiconductor storage technology, specializing in resistive random access memory (ReRam) chips. The company focuses on creating high-performance, low-power storage solutions tailored for applications in information security, Internet of Things (IoT), artificial intelligence (AI), and cloud computing. By commercializing its innovative ReRam technology, InnoStar aims to redefine storage capabilities and intelligent computing, enabling businesses to enhance security measures and meet the growing demands for efficient data storage and processing. Through its commitment to technological advancement, InnoStar Semiconductor is poised to set industry benchmarks in the semiconductor sector.

Xinyuan Semiconductor

Seed Round in 2021
Xinyuan Semiconductor focuses on the field of ReRAM.

Tavotek Biotherapeutics

Series A in 2021
Tavotek Biotherapeutics is a biopharmaceutical company dedicated to discovering, developing, and commercializing therapeutic medicines for patients with severe, underserved diseases. Led by experienced pharmaceutical executives, the company employs three distinct research and development platforms: TavoSelect, an innovative phage display library; TavoPrecise, a platform for engineering tissue-specific biologics; and TavoMIP, a multicyclic peptide platform. Tavotek's pipeline includes various product candidates targeting cancers, autoimmune conditions, and infectious diseases.

Gensciences

Series A in 2021
Gensciences is a biopharmaceutical company focused on the research and development of innovative drug therapies, particularly long-acting recombinant proteins. The company specializes in treatments for conditions such as hemophilia, metabolic diseases, and tumors. Gensciences aims to develop drugs that are not only effective and safe but also possess a high success rate, positioning itself as a leader in the global biopharmaceutical sector. Through its commitment to continuous innovation, the company strives to improve patient outcomes by providing advanced therapeutic solutions.

Biotheus

Series D in 2021
Biotheus Inc. is a biotechnology company based in Zhuhai, China, founded in 2018. The company specializes in the development and commercialization of innovative biologics, focusing primarily on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Biotheus is dedicated to addressing malignant tumors and autoimmune diseases by researching and developing next-generation multispecific antibodies. The company explores the mechanisms of regulatory T cells and innate immunity to create antibody-based therapeutics that enhance immune therapy and provide effective treatments for cancer and metabolic disorders.

SPH Health Commerce

Series B in 2021
SPH Health Commerce operates as an Internet hospital and online pharmacy, leveraging a professional pharmacy network in China to provide comprehensive services for novel pharmaceuticals. The company has developed an online prescription platform that focuses on patient-centered care, facilitating connections between patients, pharmacists, and hospitals. This platform streamlines the process of obtaining prescription medications, making it more accessible for users. In addition to its core offerings, SPH Health Commerce provides a range of professional services, including digital marketing, patient services, innovative payment solutions, and Internet hospital operations, aimed at enhancing the overall healthcare experience.

CapitalBio Technology

Private Equity Round in 2021
CapitalBio Technology, established in 2012, is a leading life science company based in Beijing, China. It specializes in developing and commercializing a wide array of healthcare solutions, including diagnostic kits for respiratory pathogens, hepatitis B, and thalassemia, as well as a broad spectrum of microarray and microfluidic chips, related instruments, software, databases, reagents, and consumables. These products cater to diverse customers, from biomedical researchers to healthcare professionals, serving applications in basic research, drug development, clinical diagnostics, biosafety, food safety, and molecular breeding. CapitalBio Technology also offers services such as Special Needs Plans (SNP) service, mRNA Expression Profiling Service, DNA methylation detection service, and sequencing services. As a subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, it employs over 500 highly educated professionals, with 86% holding at least a Bachelor's degree, including 14 doctors or post-doctorates.

InnoGrit Corporation

Series B in 2020
InnoGrit Corporation is a technology company that specializes in developing and marketing advanced data storage and transport solutions tailored for artificial intelligence and big data applications. Founded in 2016 by Zining Wu, InnoGrit is headquartered in Shanghai, China, with additional offices in Chengdu and San Jose, California. The company offers a range of PCIe Gen 3 and Gen 4 solid-state drive (SSD) processors, including models like Rainier, Shasta, Tacoma, and Shasta+, designed for enterprise and client applications. InnoGrit's innovative processors aim to enhance the speed and efficiency of data handling, reduce network latency, and facilitate smoother data transport by integrating storage, networking, and computational functions. Additionally, InnoGrit provides comprehensive support to its clients, addressing the growing demands for data backup and distribution across various sectors, including cloud computing and data warehousing.

Advaccine

Series B in 2020
Advaccine is a biotechnology company dedicated to the discovery and development of innovative vaccines, targeting both preventive and therapeutic applications. The company focuses on addressing unmet clinical needs globally, with a portfolio that includes first-in-class products. Advaccine is actively developing viral vaccine technologies aimed at various diseases, including hepatitis B, respiratory syncytial virus, type 1 diabetes, and coronavirus. Through its research pipeline, Advaccine aims to provide healthcare providers with effective solutions to improve patient outcomes.

ZStack

Series B in 2020
ZStack is a provider of cloud computing services focused on simplifying access to cloud solutions for enterprises. The company offers a range of products, including self-developed private and hybrid cloud solutions, mini hyper-converged machines, and a cloud management platform. Its services are designed to facilitate unified management of data center resources, encompassing computing, networking, and storage. ZStack has successfully served over 2,500 enterprise users and has established partnerships with over 250 cloud vendors across various sectors, including government, finance, education, internet, energy, and manufacturing. The company's mission is to promote inclusive cloud computing by reducing the barriers associated with cloud adoption.

Sight Diagnostics

Series D in 2020
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Biotheus

Series B in 2020
Biotheus Inc. is a biotechnology company based in Zhuhai, China, founded in 2018. The company specializes in the development and commercialization of innovative biologics, focusing primarily on monoclonal antibodies, recombinant proteins, and peptide biopharmaceuticals. Biotheus is dedicated to addressing malignant tumors and autoimmune diseases by researching and developing next-generation multispecific antibodies. The company explores the mechanisms of regulatory T cells and innate immunity to create antibody-based therapeutics that enhance immune therapy and provide effective treatments for cancer and metabolic disorders.

CapitalBio Technology

Series C in 2020
CapitalBio Technology, established in 2012, is a leading life science company based in Beijing, China. It specializes in developing and commercializing a wide array of healthcare solutions, including diagnostic kits for respiratory pathogens, hepatitis B, and thalassemia, as well as a broad spectrum of microarray and microfluidic chips, related instruments, software, databases, reagents, and consumables. These products cater to diverse customers, from biomedical researchers to healthcare professionals, serving applications in basic research, drug development, clinical diagnostics, biosafety, food safety, and molecular breeding. CapitalBio Technology also offers services such as Special Needs Plans (SNP) service, mRNA Expression Profiling Service, DNA methylation detection service, and sequencing services. As a subsidiary of CapitalBio Corporation and the Biological Chip Beijing National Engineering Research Center, it employs over 500 highly educated professionals, with 86% holding at least a Bachelor's degree, including 14 doctors or post-doctorates.

MicroPort Orthopedics

Private Equity Round in 2020
MicroPort Orthopedics is a producer of orthopedic products and a member of the MicroPort Scientific Corporation family of companies. Its knee and hip implants are constantly being improved just as medical procedures. It operates as a start-up of an industry powerhouse. This is critical to achieving its goal of being the growing, innovation-driven company in orthopedics. Their top priority isn’t just to help surgeons get patients back to their feet.

Shanghai Data Exchange

Series A in 2020
Shanghai Data Exchange Corp. is a prominent platform based in Shanghai, China, focused on the circulation and interconnection of commercial data. The company aims to establish itself as a pivotal hub for global data element configuration, providing efficient and secure transaction services for data circulation. It facilitates cross-regional institutional cooperation and integrates government and business data to enhance data supply and foster new digital commerce formats. Additionally, Shanghai Data Exchange is dedicated to developing a comprehensive digital business system and a fully digital data transaction system, which includes data product registration and management. Through these initiatives, the company seeks to promote the integration of Chinese digital assets into the global data ecosystem.

Westwell Lab

Series C in 2020
Westwell Lab is a Shanghai-based commercial laboratory established in 2015, focusing on the development of neuromorphic circuits and systems. The company specializes in creating advanced AI chips and autopilot systems utilizing neuromorphic engineering and monomer machine learning. By integrating innovative algorithms and custom silicon, Westwell Lab aims to deliver efficient and adaptable AI applications for various industries, including port-control systems, smart mining, and medical analysis. With a biology-inspired approach, the company seeks to enhance big data processing and embedded systems, positioning itself as a leader in the field of unconventional AI technologies.

QST Corporation

Series B in 2020
QST Corporation, founded in September 2012 and headquartered in Shanghai, China, specializes in the development and manufacturing of micro-electromechanical system (MEMS) smart sensors. The company focuses on designing high-quality sensor solutions for mobile consumer electronic devices, including smartphones, tablets, wearables, and augmented/virtual reality headsets. Its product offerings include 3-axis magnetic sensors, accelerometers, gyroscopes, barometers, pressure sensors, and light sensors, as well as combined inertial sensors. QST Corporation aims to customize intelligent applications and services for its clients, leveraging the domestic industrial support system in China to achieve rapid growth. The company is positioned to serve various sectors, including IoT applications, smart homes, and drones, contributing to the advancement of intelligent mobile terminals.

Advaccine

Venture Round in 2020
Advaccine is a biotechnology company dedicated to the discovery and development of innovative vaccines, targeting both preventive and therapeutic applications. The company focuses on addressing unmet clinical needs globally, with a portfolio that includes first-in-class products. Advaccine is actively developing viral vaccine technologies aimed at various diseases, including hepatitis B, respiratory syncytial virus, type 1 diabetes, and coronavirus. Through its research pipeline, Advaccine aims to provide healthcare providers with effective solutions to improve patient outcomes.

InnoCore

Venture Round in 2020
InnoCore is a chip design company specializing in power semiconductor technology. It engages in the design, development, and commercialization of high-power semiconductor devices, catering to various sectors including consumer electronics, communication, energy storage, automotive, and industrial applications. InnoCore also offers technical consulting and module design services, focusing on creating efficient and environmentally friendly power supply solutions. Through its innovative approach, the company aims to contribute to a sustainable power supply ecosystem.

CF PharmTech

Series E in 2020
CF PharmTech, Inc. is an independent specialty pharmaceutical company founded in 2007 and headquartered in Suzhou, China. The company specializes in the development and manufacturing of inhalation products, including metered dose inhalers, dry powder inhalers, nasal sprays, and nebulizers. CF PharmTech focuses on creating high-quality and affordable medications for the treatment of respiratory diseases such as asthma, chronic obstructive pulmonary disease (COPD), and allergic rhinitis. In addition to its product development efforts, the company provides contract manufacturing organization (CMO) services, enhancing its capabilities in the global market. With a commitment to effective patient care, CF PharmTech aims to improve management of respiratory conditions through its innovative offerings.

360

Venture Round in 2020
360 is an internet and security service company that creates 360 Security Guard, 360 Mobile Guard, 360 Security Browser, and other security solutions. 360 is headquartered in Beijing, China and was founded in 2017.

Innoviz Technologies

Series C in 2019
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate the mass-production of autonomous vehicles. The company produces InnovizPro, a solid-state LiDAR known for its performance and value in automotive applications, and InnovizOne, an advanced LiDAR sensor providing 3D sensing capabilities essential for Level 3-Level 5 autonomous driving. Additionally, Innoviz offers products for object identification, tracking, sensor fusion, mapping, and localization. Founded in 2016 and based in Rosh HaAyin, Israel, Innoviz has formed strategic alliances with notable investors including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital, 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company.

DeepWise

Series C in 2019
Beijing DeepWise Science And Technology Co., Ltd. is a company that specializes in developing artificial intelligence-based medical application software aimed at enhancing clinical imaging analysis and diagnostics. Founded in 2017 and located in Beijing, China, DeepWise focuses on early screening and diagnosis of various malignant diseases, including lung and breast cancers. Its AI-driven software improves efficiency and diagnostic accuracy in healthcare, offering solutions to hospitals, medical centers, and imaging centers. The company's technology supports the online reading and consultation of medical images, leveraging big data in the cloud to facilitate timely and accurate disease detection and treatment.

Innoviz Technologies

Series C in 2019
Innoviz Technologies designs and manufactures solid-state LiDAR sensors and develops perception software to facilitate the mass-production of autonomous vehicles. The company produces InnovizPro, a solid-state LiDAR known for its performance and value in automotive applications, and InnovizOne, an advanced LiDAR sensor providing 3D sensing capabilities essential for Level 3-Level 5 autonomous driving. Additionally, Innoviz offers products for object identification, tracking, sensor fusion, mapping, and localization. Founded in 2016 and based in Rosh HaAyin, Israel, Innoviz has formed strategic alliances with notable investors including Magna International, Samsung, Aptiv, Magma Venture Partners, Vertex Ventures, SoftBank Ventures Asia, China Merchants Capital, 360 Capital Partners, Glory Ventures, Naver, Shenzhen Capital Group, New Alliance Capital, Harel Insurance Investments and Financial Services, Phoenix Insurance Company.

Sight Diagnostics

Series C in 2019
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Thousand Oaks Biopharmaceuticals

Series A in 2019
Thousand Oaks Biopharmaceuticals, Inc., established in 2017 and headquartered in Haimen, China, specializes in contract development and manufacturing services for the biotechnology industry. The company focuses on developing technologies to produce protein and vaccine compounds, offering integrated control solutions that optimize processes, increase protein expression, and reduce production scale. Thousand Oaks provides personalized, chemically defined cell culture media, formula production, technical support, and ancillary services to its clients in the biopharmaceutical sector.

SeeYA Technology

Venture Round in 2019
SeeYA Technology is a high-tech company focused on the research and development, design, production, and sales of next-generation semiconductor OLEDoS displays. It specializes in creating high-resolution, low power consumption, and ultra-compact micro-display devices, utilizing advanced organic light-emitting diode (OLED) and silicon-based micro-display technologies. The company offers a comprehensive range of products tailored to meet the diverse needs of various industries, including augmented reality, virtual reality, drones, thermal devices, and night vision equipment. By providing reliable and user-friendly components and solutions, SeeYA Technology supports the development of intelligent devices across applications such as helmet displays, smart eyewear, and electronic viewfinders.

ZStack

Series B in 2018
ZStack is a provider of cloud computing services focused on simplifying access to cloud solutions for enterprises. The company offers a range of products, including self-developed private and hybrid cloud solutions, mini hyper-converged machines, and a cloud management platform. Its services are designed to facilitate unified management of data center resources, encompassing computing, networking, and storage. ZStack has successfully served over 2,500 enterprise users and has established partnerships with over 250 cloud vendors across various sectors, including government, finance, education, internet, energy, and manufacturing. The company's mission is to promote inclusive cloud computing by reducing the barriers associated with cloud adoption.

Guanan Information

Series B in 2018
Guanan Information is a technology-driven enterprise that provides big data and pan-security services. It focuses on core directions such as data security, cyberspace security, 5G security, artificial intelligence security, industrial Internet security, and public security. Guanan Information also provides information security solutions for operators, government, finance, electric power, public security, military, medical and other industries.

Ping An Good Doctor

Series F in 2018
Ping An Health Internet is a wholly owned subsidiary of China Ping An Group, an important member of the Internet business segment/. It was established in August 2014 with 350 million yuan registered capital and is headquartered in Shanghai, China. Companies around the network of doctors, drug network and information network formed three product lines, involving online inquiry, a plurality of segments of the doctor-patient health care management, drug O2O, electronic health records, chronic disease management, child health services. Chinese company to the mobile Internet era medical wisdom of the leader as the goal, to create a user-stop health management solutions provider, China's largest Internet to build a healthy industry ecosystem. Ping An Health Internet also developed a children's health management and chronic disease management, and other vertical applications, to meet the needs of market segments. Reform the health care system combined with the trend, the company vigorously promote the integration of physician resources.

Fusion

Venture Round in 2018
Fusion is a high-tech enterprise company that specializes in new electronic and silver pastes. It also focuses on PV silver paste, filter paste, conductive adhesive, semiconductor, and 5G materials. In addition to the positive silver paste, the company is also actively developing other silver paste products for non-photovoltaic fields. Fusion was founded on August 2015 and is headquartered in Shanghai, China.

Guanan Information

Series A in 2017
Guanan Information is a technology-driven enterprise that provides big data and pan-security services. It focuses on core directions such as data security, cyberspace security, 5G security, artificial intelligence security, industrial Internet security, and public security. Guanan Information also provides information security solutions for operators, government, finance, electric power, public security, military, medical and other industries.

ShopeX

Series D in 2017
ShopEx is a leading e-commerce software and service provider based in China, specializing in the research and development of solutions tailored for online retail. The company offers a comprehensive suite of management software designed to assist retail merchants in various aspects of their operations, including online transactions, supply chain management, and financial payments. By integrating third-party resources, ShopEx enables retail store owners to effectively develop and manage their e-commerce businesses. With a strong focus on innovation, the company boasts an experienced team that has developed proprietary technology and holds intellectual property rights in the field of e-commerce software.

Banma Kuaipao

Series C in 2017
Wuhan Banma Kuaipao Technology Co., Ltd. is a Chinese technology company that focuses on developing mobile applications for transportation services. Founded in July 2015 by Li Jia, the company is headquartered in Wuhan, China. Banma Kuaipao specializes in freight transportation through its mobile application, while also offering services for booking cabs and buses. Its platform caters to a variety of transportation needs, providing users with customized travel options that include commercial vehicles, passenger cars, and buses.

Shenzhen Jiedian Technology

Series A in 2017
Shenzhen Jiedian Technology is a start-up focused on the rental of mobile device power banks. The company specializes in providing portable charging solutions that allow users to charge their mobile phones and tablets conveniently in public spaces. With a user-friendly rental service, Jiedian enables customers to access charging devices anytime and anywhere, ensuring a secure and efficient charging experience. This service addresses the growing demand for on-the-go power solutions in today's mobile-dependent environment.

eBways.com

Series B in 2017
eBways.com is an online textile form that deals with the selling of dresses. The customer can place an order online and get the products.

CooTek

Series D in 2017
CooTek, founded in 2008 and headquartered in Shanghai, is a global mobile internet company that specializes in developing innovative mobile applications and artificial intelligence technologies. The company is best known for its flagship app, TouchPal Keyboard, which enhances input experiences for users on both Android and iPhone devices. CooTek's diverse portfolio includes content-rich applications across various categories, such as online literature, mobile games, and scenario-based apps focused on fitness, healthcare, and lifestyle. With a significant presence in the United States, CooTek has achieved a broad user base, boasting an average of 213.7 million monthly active users globally as of September 2018. The company is committed to technological innovation, holding over 170 patents and actively pursuing advancements in artificial intelligence through its dedicated AI lab and big data development center in Silicon Valley. CooTek's research has been recognized in prominent discussions at major big data and AI conferences.

Sanrise Tech

Venture Round in 2017
Shenzhen Sanrise Tech is a specialized enterprise focused on the design of high-performance MOSFET chips and power semiconductors. The company develops a range of semiconductor products, including IGBT, SnowMOS™ (Super Junction MOSFET), TTMOS™ (SGT MOSFET), and SIC series devices. These products are integral to various applications, such as industrial production, automotive products, power electronics, new energy technologies, communication systems, and data centers. Sanrise Tech's innovations support sectors including automotive charging solutions, new energy vehicles, consumer appliances, and imaging products, providing clients with high-quality semiconductor inputs essential for efficient power management and performance.

Sight Diagnostics

Series B in 2016
Sight Diagnostics Ltd. is a medical device company based in Tel Aviv, Israel, that specializes in blood diagnostics using advanced computer vision technology. The company focuses on improving health outcomes with rapid, accurate, and convenient diagnostic solutions. His flagship product, Parasight, is a malaria detection device that has performed nearly one million tests across 24 countries, though it is not available for sale in the United States. Sight Diagnostics has also developed Sight OLO, an FDA-cleared blood analyzer that requires only two drops of blood to deliver lab-grade Complete Blood Count results within minutes. Combining machine vision, AI, and innovations in multiple scientific fields, Sight Diagnostics aims to facilitate effective healthcare delivery and expand its commercial presence across five continents.

Zhaoxin

Venture Round in 2016
Shanghai Zhaoxin Semiconductor Co., Ltd. specializes in the design and manufacture of core processor chips, including central processing units, graphics processing units, and supporting chipsets. Established in 2013, the company is headquartered in Shanghai and has additional offices in major cities such as Beijing, Wuhan, Shenzhen, and Xi’an. Zhaoxin focuses on delivering high-performance and reliable general-purpose processors through independent innovation while maintaining compatibility with mainstream development routes. Utilizing advanced lithography processes, including 40nm and 28nm technologies, the company develops a range of intelligent terminal processor chips, notably the ARM Cortex AX series and various System on Chip (SoC) products within its Elite series.

KJT.com

Venture Round in 2016
KJT.com operates an eCommerce platform focused on facilitating cross-border trade for Chinese consumers seeking high-quality foreign products. The company provides a marketplace that connects international brands with Chinese buyers, offering a range of shopping guides and transaction services to ensure safe and reliable purchases. By streamlining the process of accessing foreign commodities, KJT.com enhances the shopping experience for consumers looking for authentic products from around the globe.

KanS

Angel Round in 2015
KanS is a cosmetics company that specializes in consumer goods, particularly personal care. It is a scientific anti-aging skin care brand that specializes in Asian skin beauty. It uses scientific research to shape product strength and is committed to providing young consumers with Scientific and professional, precise and efficient skin anti-aging solutions. It is supported by dual scientific research laboratories in China and Japan, as well as a high-quality supply chain system.

Baby Elephant

Angel Round in 2015
Baby Elephant provides baby care, baby skin care, baby bath, detergent, laundry, softener, mosquito repellent, cutlery feeding, pregnancy care, beautiful skin, facial kits, facial masks, cleansing milk, stretch mark massage oil, body care, isolation, sun protection, makeup, antibacterial and anti-mite cleaning series, late cherry revitalizing series, tranexamic acid brightening series, antarctica series, and more products.

UnionPay International

Venture Round in 2015
UnionPay International Co., Ltd. is a Shanghai-based subsidiary of China UnionPay that specializes in electronic payment services for cardholders and merchants both in China and globally. Established in 2012, the company offers a range of products including debit and credit cards, mobile and online payment solutions, chip cards, and mobile point-of-sale (mPOS) terminals. UnionPay International partners with over 300 institutions worldwide, enabling card acceptance in 148 countries and regions outside the Chinese mainland and facilitating card issuance in more than 30 locations. The company focuses on providing secure and cost-effective cross-border payment services, meeting the needs of the world's largest cardholder base while ensuring convenient local services for UnionPay cardholders and merchants.

HQBIOTEC

Series B in 2014
HQBIOTEC is a development of the in vitro diagnostic industry. They provide products for producing gynaecology and medical laboratory diagnostic products. An online inquiry form is available on the company's website.

Yunnan Jianzhijia Health

Series A in 2014
Jianzhijia adheres to the corporate mission of "establishing credibility with professionalism, high-quality service, and striving to achieve customer satisfaction", adhering to the business positioning of "health + professional + convenience", and practicing "quality assurance, professional service, and customer satisfaction" The service tenet of the company, the implementation of the overall strategy of "group management, diversified operations, and national expansion", relying on the industry's leading operation management technology, efficient logistics system and continuously optimized information system three pillars, starting from Kunming, Based in Yunnan, rooted in the southwest, steadily developing towards the whole country.

Yicai

Series A in 2010
Yicai is a finance and economics company. They provide services for distributing text and video content to major media platforms and financial institutions. Their customers' inquiries are addressed through phone, email, and online applications.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.